Pricing Log in Create free account

Quest Diagnostics Incorporated (DGX) vs Medpace Holdings, Inc. (MEDP)

Quest Diagnostics Incorporated and Medpace Holdings, Inc. are both Diagnostics & Research companies. Quest Diagnostics Incorporated is the larger, with a market value of $28.0B against $17.8B — 1.6× the size. Quest Diagnostics Incorporated trades at the lower P/E: 25.0× against 34.6×. Medpace Holdings, Inc. grew revenue faster over the last twelve months: 20.4% against 9.13%. Medpace Holdings, Inc. has the higher net margin (18.2% vs 9.50%) and the lower return on invested capital (0.00% vs 8.48%). Across the 22 metrics below, Medpace Holdings, Inc. leads on 12 and Quest Diagnostics Incorporated on 10.

Valuation

Metric DGX MEDP Diagnostics & Research median
P/E 24.98 34.57 34.52
P/S 2.36 6.25 4.24
P/B 3.52 30.31 3.42
Price to free cash flow 20.34 26.56 33.51
EV/EBITDA 14.18 27.01 23.44
EV/Sales 2.76 6.04 5.18
Earnings yield 4.00% 2.89% (1.50%)
Free cash flow yield 4.92% 3.77% 0.00%

Profitability

Metric DGX MEDP Diagnostics & Research median
Gross margin 33.11% 72.24% 48.32%
Operating margin 14.55% 21.39% (5.68%)
Net margin 9.50% 18.24% (4.10%)
Free cash flow margin 11.61% 23.52% 0.00%
Return on equity 14.76% 117.88% 0.00%
Return on assets 6.73% 25.54% (6.05%)
Return on invested capital 8.48% 0.00% 0.00%

Growth

Metric DGX MEDP Diagnostics & Research median
Revenue growth (TTM) 9.13% 20.35% 8.99%
EPS growth (last fiscal year) 13.78% 20.98% 20.36%
Revenue growth, 5-year CAGR 3.18% 22.27% 7.30%
Net income growth, 5-year CAGR (7.06%) 25.50% 0.00%

Health

Metric DGX MEDP Diagnostics & Research median
Debt to equity 0.70 0.00 0.01
Current ratio 1.70 0.83 2.27
Net debt to EBITDA 2.47 (0.88) 0.68

Dividend

Metric DGX MEDP Diagnostics & Research median
Dividend yield 1.33% — 0.67%
Payout ratio 0.34 — 0.20

Size

Metric DGX MEDP Diagnostics & Research median
Market cap 28.03b 17.76b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack